Analyses of prognostic indices of chronic liver failure caused by hepatitis virus

World Journal of Gastroenterology

Volumn 11, Issue 18, 2005, Pages 2841-2843

  Li, Xiao Mao ^a   Ma, Lin ^a   Yang, Yue Bo ^a   Shi, Zhong Jie ^a   Zhou, Shui Sheng ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

Chronic liver failure; Complications; Hepatitis; Laboratory indices; Prognostic indices; Regression equation

Indexed keywords

ALBUMIN; ALPHA FETOPROTEIN; BILIRUBIN;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; BILIRUBIN BLOOD LEVEL; CHRONIC DISEASE; CLINICAL FEATURE; COMPARATIVE STUDY; DIGESTIVE SYSTEM HEMORRHAGE; ECHOGRAPHY; FEMALE; HEPATIC ENCEPHALOPATHY; HEPATITIS VIRUS; HEPATORENAL SYNDROME; HUMAN; LABORATORY TEST; LIVER FAILURE; LIVER SIZE; LOGISTIC REGRESSION ANALYSIS; LUNG INFECTION; MAJOR CLINICAL STUDY; MALE; PREDICTION; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTHROMBIN TIME; RETROSPECTIVE STUDY; RISK FACTOR; STATISTICAL SIGNIFICANCE;

EID: 18944361978     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v11.i18.2841     Document Type: Article

References (28)

1. Li XM, Liu SL, Li X, Huang HJ, Lu JX, Gao ZL. The relative study of Hepatitise B virus DNA in maternal blood, umbilical blood and breast milk. Zhongshan Yike Daxue Xuebao 2000; 21: 233-235
2. Merle P, Trepo C, Zoulim F. Current management strategies for hepatitis B in the elderly. Drugs Aging 2001; 18: 725-735
3. Hamdani-Belghiti S, Bouazzaou NL. Mother-child transmission of hepatitis B virus. State of the problem and prevention. Arch Pediatr 2000; 7: 879-882
4. Zhang DF. Etiopathogenesis of hepatitis B virus and clinic. Chongqing. Chongqing Publishing House 1998: 264
5. Xu JZ, Gao L. Investigation into problems about diagnosis and treatment of fulminant hepatitis. Dongnan Guofang Yiyao 2003; 5: 316-317
6. Prevention and cure program for viral hepatitis. Chin J Hepatol 2000; 8: 324-329
7. Xiao RM, Huang LJ, Chen ZH. Primary investigation into mortality correlated ratio and clinical application of fulminant hepatitis. Chin J Epidemiol 1993; 14: 204
8. Takahashi Y, Kumada H, Shimizu M, Tanikawa K, Kumashiro R, Omata M, Ehata T, Tsuji T, Ukida M, Yasunaga M. A multicenter study on the prognosis of fulminant viral hepatitis: early prediction for liver transplantation. Hepatology 1994; 19: 1065-1071
9. Ogasawara J, Watanabe-Fukunaga R, Adachi M, Matsuzawa A, Kasugai T, Kitamura Y, Itoh N, Suda T, Nagata S. Lethal effect of the anti-Fas antibody in mice. Nature 1993; 364: 806-809
10. Leist M, Gantner F, Bohlinger I, Tiegs G, Germann PG, Wendel A. Tumor necrosis factor-induced hepatocyte apoptosis precedes liver failure in experimental murine shock models. Am J Pathol 1995; 146: 1220-1234
11. Zang GQ, Zhou QX, Yu H, Xie Q, Wang B, Zhao GM, Guo Q, Xiang YQ, Liao D. The roles of TNF-α induced hepatocyte apoptosis in the development of fulminant liver failure. Chin J Dig 2000; 20: 163-166
12. Peng WW. Viral Hepatitis. In: Epidemiology. Beijing: People's Medical Publishing House 1995: 24
13. Davern II TJ, Scharschmidt BF. Biochemical liver test. In: Feldman M, Scharschmidt BF, Sleisenger MH. Eds. Sleisenger & Fordtran's Gastrointestinal and Liver Disease. 6th ed. Philadelphia: W.B. Saunders Co 1998: 1112
14. Zou ZS, Chen JM, Xin SJ, Xing HQ, Li BS, Li JY, Shen HH, Liu YP. Single factor study of prognosis from 520 cases with chronic severe hepatitis. Chinese J Exp Clin Virol 2002; 16: 246-248
15. Wang SQ, Li QY, Li YL, Zhao HQ. Clinical significance of AFP in fulminant hepatitis. Ganzang 1999; 4: 116
16. Luo CY, Zhang XY. Preventive and treatment measures of hepatorenal symptom in fulminant hepatitis. Zhongguo Shiyong Neike Zazhi 1995; 15: 137-139
17. Qiu DK. Complications of chronic liver disease-Current conception of diagnosis and treatment. Shanghai: Shanghai Sci Technol Publishing House 2001: 76
18. Xu JZ, Liu GZ. Preventive and treatment measures of digestive tract hemorrhage in fulminant hepatitis. Zhongguo Shiyong Neike Zazhi 1995; 15: 131-132
19. Sun HQ, Luo CY. Analysis of prognostic factors of chronic fulminant hepatitis. Ganzang 2000; 5: 232-233
20. Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, D'Amico G, Dickson ER, Kim WR. A model to predict survival in patients with end-stage lever disease. Hepatology 2001; 33: 464-470
21. Bazarah SM, Peltekian KM, McAlister VC, Bitter-Suermann H, MacDonald AS. Utility of MELD and Child-Turcotte-Pugh scores and the Canadian waitlisting algorithm in predicting short-term survival after liver transplant. Clin Invest Med 2004; 27: 162-167
22. Trotter JF, Brimhall B, Arjal R, Phillips C. Specific laboratory methodologies achieve higher model for endstage liver disease (MELD) scores for patients listed for liver transplantation. Liver Transpl 2004; 10: 995-1000
23. Olthoff KM, Brown RS Jr, Delmonico FL, Freeman RB, McDiarmid SV, Merion RM, Millis JM, Roberts JP, Shaked A, Wiesner RH, Lucey MR. Summary report of a national conference: Evolving concepts in liver allocation in the MELD and PELD era. Liver Transpl 2004; 10(Suppl 10): A6
24. Heuman DM, Abou-Assi SG, Habib A, Williams LM, Stravitz RT, Sanyal AJ, Fisher RA, Mihas AA. Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early death. Hepatology 2004; 40: 802-810
25. Jacob M, Copley LP, Lewsey JD, Gimson A, Toogood GJ, Rela M, van der Meulen JH. UK and ireland liver transplant audit. Pretransplant MELD score and post liver transplantation survival in the UK and Ireland. Liver Transpl 2004; 10: 903-907
26. Roberts MS, Angus DC, Bryce CL, Valenta Z, Weissfeld L. Survival after liver transplantation in the United States: a disease-specific analysis of the UNOS database. Liver Transpl 2004; 10: 886-897
27. Lo CM, Fan ST, Liu CL, Yong BH, Wong Y, Lau GK, Lai CL, Ng IO, Wong J. Lessons learned from one hundred right lobe living donor liver transplants. Ann Surg 2004; 240: 151-158
28. Santori G, Andorno E, Antonucci A, Morelli N, Bottino G, Mondello R, Valente R, Panaro F, Ravazzoni F, Di Domenico S, Savelli A, Valente U. Potential predictive value of the MELD score for short-term mortality after liver transplantation. Transplant Proc 2004; 36: 533-534